Related Experiment Video
Updated: Jul 10, 2026

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension
Published on: December 28, 2015
Production of humanized glycoproteins in bacteria and yeasts
Yasunori Chiba1, Yoshifumi Jigami
1Research Institute for Cell Engineering, National Institute of Advanced Industrial Science and Technology, Tsukuba Central 6, Tsukuba, Japan.
Abstract:
A suitable glycan structure is required for optimal protein-based therapeutics, such as antibody-dependent cell cytotoxicity in therapeutic antibodies, enzyme replacement therapy for lysosomal diseases, and controlled clearance of cytokines from the blood. Expressing proteins in unicellular organisms such as bacteria and yeast would be commercially advantageous compared with mammalian cells if these organisms could be engineered to produce human-type glycans. Although using bacteria and yeast to produce humanized glycoproteins and to conduct glycan remodeling of proteins remain a long-term goal for microbiologists and biochemists, recent studies in the field of microbial glycobiology in combination with synthetic chemical techniques suggest that this dream is close to being realized.
Related Concept Videos
Production of Pharmaceuticals
Bioreactor Controls-III
Production of Antibiotics
Upstream Processing
Recombinant DNA
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...

